» Articles » PMID: 17263339

Detection of Protein Biomarkers Using RNA Aptamer Microarrays and Enzymatically Amplified Surface Plasmon Resonance Imaging

Overview
Journal Anal Chem
Specialty Chemistry
Date 2007 Feb 1
PMID 17263339
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

A methodology for the detection of protein biomarkers at picomolar concentrations that utilizes surface plasmon resonance imaging (SPRI) measurements of RNA aptamer microarrays is developed. The adsorption of proteins onto the RNA microarray is detected by the formation of a surface aptamer-protein-antibody complex. The SPRI response signal is then amplified using a localized precipitation reaction catalyzed by the enzyme horseradish peroxidase that is conjugated to the antibody. This enzymatically amplified SPRI methodology is first characterized by the detection of human thrombin at a concentration of 500 fM; the appropriate thrombin aptamer for the sandwich assay is identified from a microarray of three potential thrombin aptamer candidates. The SPRI method is then used to detect the protein vascular endothelial growth factor (VEGF) at a biologically relevant concentration of 1 pM. VEGF is a signaling protein that has been used as a serum biomarker for rheumatoid arthritis, breast cancer, lung cancer, and colorectal cancer and is also associated with age-related macular degeneration.

Citing Articles

One Single Tube Reaction of Aptasensor-Based Magnetic Sensing System for Selective Fluorescent Detection of VEGF in Plasma.

Kou H, Lo S, Wang C Biosensors (Basel). 2023; 13(6).

PMID: 37366939 PMC: 10296741. DOI: 10.3390/bios13060574.


Aptamer-based rapid diagnosis for point-of-care application.

Futane A, Narayanamurthy V, Jadhav P, Srinivasan A Microfluid Nanofluidics. 2023; 27(2):15.

PMID: 36688097 PMC: 9847464. DOI: 10.1007/s10404-022-02622-3.


Two Biosensors for the Determination of VEGF-R2 in Plasma by Array SPRi.

Oldak L, Zelazowska-Rutkowska B, Lesniewska A, Mrozek P, Skoczylas M, Lukaszewski Z Molecules. 2023; 28(1).

PMID: 36615347 PMC: 9822109. DOI: 10.3390/molecules28010155.


Luminescent Aptamer-Based Bioassays for Sensitive Detection of Food Allergens.

Calabria D, Zangheri M, Shariati Pour S, Trozzi I, Pace A, Lazzarini E Biosensors (Basel). 2022; 12(8).

PMID: 36005040 PMC: 9405952. DOI: 10.3390/bios12080644.


Rapid selection of aptamers based on protein microarray.

Yu F, Li H, Sun W, Xu D, He F RSC Adv. 2022; 9(17):9762-9768.

PMID: 35520705 PMC: 9062193. DOI: 10.1039/c8ra09232j.


References
1.
Raben D, Ryan A . Vascular-targeting agents and radiation therapy in lung cancer: where do we stand in 2005?. Clin Lung Cancer. 2005; 7(3):175-9. DOI: 10.3816/CLC.2005.n.032. View

2.
Li Y, Lee H, Corn R . Fabrication and characterization of RNA aptamer microarrays for the study of protein-aptamer interactions with SPR imaging. Nucleic Acids Res. 2006; 34(22):6416-24. PMC: 1702490. DOI: 10.1093/nar/gkl738. View

3.
Adams J, Carder P, Downey S, FORBES M, MacLennan K, Allgar V . Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res. 2000; 60(11):2898-905. View

4.
Brody E, Gold L . Aptamers as therapeutic and diagnostic agents. J Biotechnol. 2000; 74(1):5-13. DOI: 10.1016/s1389-0352(99)00004-5. View

5.
Nelson B, Grimsrud T, Liles M, Goodman R, Corn R . Surface plasmon resonance imaging measurements of DNA and RNA hybridization adsorption onto DNA microarrays. Anal Chem. 2001; 73(1):1-7. DOI: 10.1021/ac0010431. View